Cargando…
Inhaled corticosteroids for the treatment of COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused severe illness and mortality for millions worldwide. Despite the development, approval and rollout of vaccination programmes globally to prevent infection by SARS-CoV-2 and the development of coronavirus disease 201...
Autores principales: | Bafadhel, Mona, Faner, Rosa, Taillé, Camille, Russell, Richard E.K., Welte, Tobias, Barnes, Peter J., Agustí, Alvar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724831/ https://www.ncbi.nlm.nih.gov/pubmed/36450371 http://dx.doi.org/10.1183/16000617.0099-2022 |
Ejemplares similares
-
Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021) -
Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
por: Nicolau, Dan V, et al.
Publicado: (2020) -
Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021) -
When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2020) -
Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis
por: Baker, Jonathan R, et al.
Publicado: (2022)